Treace Medical Concepts (TMCI) Non-Current Assets (2020 - 2026)
Treace Medical Concepts (TMCI) posted Non-Current Assets of $60.6 million for Q1 2026, up 3.59% on a QoQ basis from $58.5 million in Q4 2025, and up 7.48% year-over-year from $56.4 million in Q1 2025.
Treace Medical Concepts (TMCI) Non-Current Assets (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Non-Current Assets history runs 7 years deep, the most recent figure standing at $60.6 million for Q1 2026.
- Quarterly Non-Current Assets rose 7.48% year-over-year to $60.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $236.6 million (up 6.6% YoY) and the FY2025 annual result came in at $58.5 million, up 5.09% from the prior year.
- Non-Current Assets was $60.6 million for Q1 2026 at Treace Medical Concepts, up from $58.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $60.6 million in Q1 2026 and bottomed at $19.2 million in Q1 2022.
- A 5-year average of $46.8 million and a median of $54.5 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets jumped 1966.63% — and 2025, when it increased 1.95%.
- Treace Medical Concepts' Non-Current Assets stood at $25.6 million in 2022, then surged by 108.99% to $53.5 million in 2023, then gained by 4.0% to $55.7 million in 2024, then advanced by 5.09% to $58.5 million in 2025, then increased by 3.59% to $60.6 million in 2026.
- Business Quant data shows TMCI's Non-Current Assets at $60.6 million in Q1 2026, $58.5 million in Q4 2025, and $58.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | 60.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.63 Mn |
| Dec 31, 2025 | 58.53 Mn |
| Sep 30, 2025 | 58.59 Mn |
| Jun 30, 2025 | 58.84 Mn |
| Mar 31, 2025 | 56.41 Mn |
| Dec 31, 2024 | 55.69 Mn |
| Sep 30, 2024 | 55.32 Mn |
| Jun 30, 2024 | 54.53 Mn |
| Mar 31, 2024 | 55.33 Mn |
| Dec 31, 2023 | 53.55 Mn |
| Sep 30, 2023 | 53.22 Mn |
| Jun 30, 2023 | 51.55 Mn |
| Mar 31, 2023 | 26.04 Mn |
| Dec 31, 2022 | 25.62 Mn |
| Sep 30, 2022 | 28.54 Mn |
| Jun 30, 2022 | 23.53 Mn |
| Mar 31, 2022 | 19.20 Mn |
| Dec 31, 2021 | 2.85 Mn |
| Sep 30, 2021 | 2.23 Mn |
| Jun 30, 2021 | 1.48 Mn |